Human papillomavirus vaccine efficacy against invasive, HPV-positive cancers: population-based follow-up of a cluster-randomised trial

BACKGROUND: Human papillomavirus (HPV) vaccination protects against HPV, a necessary risk factor for cervical cancer. We now report results from population-based follow-up of randomised cohorts that vaccination provides HPV-type-specific protection against invasive cancer. METHODS: Individually and/...

Descripción completa

Detalles Bibliográficos
Autores principales: Lehtinen, Matti, Lagheden, Camilla, Luostarinen, Tapio, Eriksson, Tiina, Apter, Dan, Bly, Anne, Gray, Penelope, Harjula, Katja, Heikkilä, Kaisa, Hokkanen, Mari, Karttunen, Heidi, Kuortti, Marjo, Nieminen, Pekka, Nummela, Mervi, Paavonen, J, Palmroth, Johanna, Petäjä, Tiina, Pukkala, Eero, Soderlund-Strand, Anna, Veivo, Ulla, Dillner, Joakim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719207/
https://www.ncbi.nlm.nih.gov/pubmed/35149535
http://dx.doi.org/10.1136/bmjopen-2021-050669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719207/
https://www.ncbi.nlm.nih.gov/pubmed/35149535
http://dx.doi.org/10.1136/bmjopen-2021-050669

Ejemplares similares